APOTEX CORP Company Profile
✉ Email this page to a colleague
What is the competitive landscape for APOTEX CORP, and what generic and branded alternatives to APOTEX CORP drugs are available?
APOTEX CORP has thirteen approved drugs.
There is one tentative approval on APOTEX CORP drugs.
Summary for APOTEX CORP
| US Patents: | 0 |
| Tradenames: | 11 |
| Ingredients: | 11 |
| NDAs: | 13 |
| Patent Litigation for APOTEX CORP: | See patent lawsuits for APOTEX CORP |
| PTAB Cases with APOTEX CORP as petitioner: | See PTAB cases with APOTEX CORP as petitioner |
Drugs and US Patents for APOTEX CORP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex Corp | RILUZOLE | riluzole | TABLET;ORAL | 091300-001 | Jun 18, 2013 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Apotex Corp | TOLTERODINE TARTRATE | tolterodine tartrate | TABLET;ORAL | 200164-002 | Sep 25, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Apotex Corp | MYCOPHENOLATE MOFETIL | mycophenolate mofetil | CAPSULE;ORAL | 090419-001 | Apr 22, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Apotex Corp | LOSARTAN POTASSIUM | losartan potassium | TABLET;ORAL | 090790-003 | Oct 6, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Apotex Corp | CABERGOLINE | cabergoline | TABLET;ORAL | 201503-001 | Mar 8, 2013 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
